Lucira Health Inc (LHDX) Stock
LHDX is no longer traded. Lucira Health was delisted from the Nasdaq in May 2023.
Prices on this page are historical; the last trade was May 5, 2023 at $0.03.
Lucira Health stock price history
LHDX final trading statistics
- Final close
- $0.03
- Final trading day
- May 5, 2023
- Market cap at delisting
- $18.36M
- Shares outstanding
- 40.60M
- Final 52-week range
- $0.03 – $3.58
- Avg. volume (final 3 mo.)
- 15,245,473
- All-time high (split-adj.)
- $37.00 · Feb 2021
- All-time low (split-adj.)
- $0.03 · May 2023
- Return since IPO
- -99.8%
- Beta
- 3.76
- Book value / share
- $1.50
- Price / book
- 0.02
Lucira Health annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $93.06M | -$64.8M | -$1.38 |
| FY2020 | $269.0K | -$44.9M | -$2.78 |
| FY2019 | $0.00 | -$9.1M | — |
| FY2018 | $0.00 | -$6.7M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Lucira Health Inc
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Lucira Health stock FAQ
What happened to Lucira Health stock?
Lucira Health stock was delisted from the Nasdaq. Its final close was $0.03 on May 5, 2023.
Is LHDX stock still trading?
No. LHDX was delisted from the Nasdaq in May 2023 and no longer trades on a U.S. exchange.
What was the last price of LHDX stock?
LHDX closed at $0.03 on its final trading day, May 5, 2023, for a market value of about $18.36M.
What were Lucira Health's revenue and earnings in its last full fiscal year?
Lucira Health reported revenue of $93.06M and net income of -$64.8M in fiscal 2021, its last full year as a public company.
When did Lucira Health go public?
Lucira Health Inc stock began trading on February 5, 2021.